The diagnostics company Gradientech today announces that instrument and sample preparation kit as part of the previously CE-IVD marked QuickMIC® system, have been registered as IVDR Class A in compliance with the new European IVD regulation.
The diagnostics company Gradientech today announces that instrument and sample preparation kit as part of the previously CE-IVD marked QuickMIC® system, have been registered as IVDR Class A in compliance with the new European IVD regulation.
Diagnostikföretaget Gradientech meddelar idag att instrument och provberedningskit i det sedan tidigare CE-IVD-registrerade QuickMIC®-systemet, har registrerats som IVDR Klass A i enlighet med den nya europeiska IVD-förordningen.
The diagnostics company Gradientech today announces an exclusive distribution agreement with Biomedica for the commercialization of QuickMIC® in Austria, Switzerland and Central Eastern Europe.
Diagnostikföretaget Gradientech har tecknat ett exklusivt distributionsavtal för kommersialiseringen av QuickMIC® i Österrike, Schweiz och östra central Europa med Biomedica.
Gradientech is hosting a live webinar on the 29th of June 2022 at 14:00 (CEST). Current developments in next generation antibiotic susceptibility testing (AST) and state of the art performance with QuickMIC® will be presented.
Gradientech is hosting a live webinar on the 29th of June 2022 at 14:00 (CEST). Current developments in next generation antibiotic susceptibility testing (AST) and state of the art performance with QuickMIC® will be presented.
Gradientech bjuder in till ett direktsänt webinarium den 29 juni 2022 kl. 14:00 (CEST). Aktuell utvecklingen inom nästa generations testning av antibiotikaresistens (AST) och QuickMIC®-systemets prestanda kommer att presenteras.
The diagnostics company Gradientech today announces CE-IVD registration of its first diagnostic product QuickMIC® and its gram-negative panel. The QuickMIC system will be the fastest system for growth-based testing of antibiotic susceptibility for sepsis patients.
Diagnostikföretaget Gradientech meddelar idag CE-IVD-registrering av sin första diagnostikprodukt QuickMIC® och dess gram-negativa panel. QuickMIC-systemet blir det snabbaste på marknaden för tillväxtbaserad testning av antibiotikaresistens hos sepsispatienter.
Gradientech AB (publ) delårsrapport för Q1 2022 är nu tillgänglig på bolagets hemsida www.gradientech.se.